Bone Biologics Corporation (BBLG)
NASDAQ: BBLG · Real-Time Price · USD
2.460
-0.020 (-0.81%)
Oct 20, 2025, 4:00 PM EDT - Market closed

Bone Biologics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202015 - 2019
Period Ending
Oct '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
422336230
Upgrade
Market Cap Growth
19.73%-4.06%-24.75%-91.19%-84.17%87.50%
Upgrade
Enterprise Value
-2-1-2-249241
Upgrade
Last Close Price
2.485.6427.12301.975068.8027000.02
Upgrade
PB Ratio
0.630.670.830.545.54-16.80
Upgrade
P/TBV Ratio
0.670.670.830.545.54-
Upgrade
Debt / Equity Ratio
------0.86
Upgrade
Quick Ratio
16.358.803.642.9666.81-
Upgrade
Current Ratio
17.2410.224.503.3366.81-
Upgrade
Return on Equity (ROE)
-88.80%-128.71%-202.15%-23.71%--
Upgrade
Return on Assets (ROA)
-52.63%-69.40%-96.34%-30.20%--
Upgrade
Return on Capital (ROIC)
-56.45%-82.53%-133.11%-36.59%-29.94%-
Upgrade
Earnings Yield
-167.28%-177.53%-370.63%-46.27%-4.42%-0.79%
Upgrade
FCF Yield
-74.51%-178.07%-395.77%-111.16%-3.37%-0.19%
Upgrade
Buyback Yield / Dilution
-369.71%-476.60%----
Upgrade
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q